Business Context and Reporting Period
This Form 8-K is filed by PharmAthene, Inc. (not Altimmune, Inc.) on May 15, 2009. The report announces the issuance of a press release detailing financial results for the quarter ended March 31, 2009. The registrant is incorporated in Delaware with principal executive offices in Annapolis, Maryland.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the quarterly results have been announced via a press release.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, or specific risk factors. It includes a standard disclaimer stating that the information in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (the press release dated May 15, 2009).
- Confirm the company name is PharmAthene, Inc., as the input metadata incorrectly listed "Altimmune, Inc."
- Check for any subsequent filings that may incorporate the press release by reference.